GL1X · GenesisL1 explorer

Research workbench

Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with VLA-UNK-82501c2c-1 (Mpro-P0153)

Analyse Group deposition SARS-CoV-2 main protease in complex with inhibitors from the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7GJ1
Type
protein
Length
606 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.95
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
QJR, CL
Pockets
8 · best druggability 0.76

Structure

x-ray diffraction · resolution 1.95 · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30125% helix, 29% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein30527% helix, 29% strandP0DTD1

Ligands and binding sites

  • QJR · 2-(3,4-dichlorophenyl)-N-(2,7-naphthyridin-4-yl)acetamide · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains A
  • DMS · Dimethyl sulfoxide · additive · 12 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19740.760.7979DMS
2750.690.9528DMS
3810.610.8919DMS
43480.530.7350DMS
51890.490.7627empty

Interfaces

1 interface between chains.

  • A–B · 1474 Ų buried · 37 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.